FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Democrats pressure Mike Johnson to keep House in Washington over ‘rapidly developing’ Iran operation

Newsom declares ‘Trump is in retreat’ after Noem ouster, demands Miller be ‘next’

Pentagon Declares Major AI Company a Threat to Military Supply Chain

Trump Lays Out His Demands to Iranian Leaders, Vows to ‘MIGA’ If They Comply

Farage heads to Mar-a-Lago to reinforce Trump’s opposition to Chagos Islands deal

Khamenei’s secret bunker under Tehran destroyed by Israeli military jet bombardment

53 Dems vote against declaring Iran a state sponsor of terror

Capitol Hill Dems hail Trump’s DHS ouster of Noem after heated Senate hearing

FBI Agents Search New Home in Nancy Guthrie Disappearance

Fact Check: Did a US F-15E Just Crash in Iran?

Man who was on parole after prior violent offenses now accused in 4 murders

Soros-backed, pro-China network fuels protests against US tech firms

Dem Senate hopeful holds event at bookstore selling ‘ABOLISH ICE’ merch despite pledge to ‘secure the border’

Congress attempts a $39 billion return to the public

Iran war certain to impact wind-down of US military aid to Israel

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”